H 4042

South Carolina General Assembly
126th Session, 2025-2026
Bill 4042
Indicates Matter Stricken
Indicates New Matter
(Text matches printed bills. Document has been reformatted to meet World Wide Web specifications.)
Indicates Matter Stricken
Indicates New Matter
Amended
May 13, 2026
H. 4042
Introduced by Reps. Kilmartin, White, Gilreath,
Cromer, Guffey, Harris, Hager, McCravy, Edgerton, Terribile, Magnuson,
Lastinger, D. Mitchell, Sessions, Chapman, Brewer, Lawson, Oremus, Hartz,
Vaughan, Pedalino, Teeple, Landing, Rankin, Schuessler, Ligon, Long, Sanders,
Ford, T. Moore, Forrest, Chumley, Bowers, Taylor, Hixon, M. M. Smith, Gibson
and Duncan
S. Printed 5/13/26--S.  [SEC
5/14/2026 10:46 AM]
Read the first time May 6, 2026
________
A bill
TO AMEND THE SOUTH CAROLINA CODE OF LAWS BY ADDING SECTION
44-53-150 SO AS TO AUTHORIZE THE OVER-THE-COUNTER SALE OF IVERMECTIN TABLETS.
    Amend Title To Conform
Be it enacted by the
General Assembly of the State of South Carolina:
SECTION 1.  Article 3, Chapter 53, Title 44 of the S.C. Code is
amended by adding:
    Section
44-53-150. (A) Notwithstanding any
provision of law to the contrary, FDA-approved ivermectin product labeled for
human use may be made available to the public for over-the-counter purchase in
this State to any person who is at least eighteen years of age, provided
ivermectin dispensed pursuant to this section must be maintained in an area
accessible only to pharmacy personnel. No prescription order shall be required
for such purchase.
    (B)
The Board of Pharmacy shall adopt rules to establish standard procedures for
the dispensing of ivermectin including the following:
       (1)
providing the patient with a screening risk assessment tool;
       (2)
providing the patient with information on the indications and contraindications
for the use of ivermectin, the appropriate method for using ivermectin, the
importance of medical follow-up, and any other information considered
appropriate by the department; and
       (3)
prohibitions on dispensing ivermectin when contraindications or clinically
significant drug interactions exist based on a patient's medication profile or
medical conditions.
    (C)
The Board of Pharmacy shall not require documentation beyond that reasonably
necessary to demonstrate compliance with this section and shall adopt rules
necessary to implement this section within ninety days of the effective date.
    (D) A
pharmacist may rely upon information provided by or on behalf of the patient
when acting pursuant to this section and is not liable for incomplete,
inaccurate, or omitted information provided by or on behalf of a patient. A
pharmacist acting in good faith and with reasonable care pursuant to this
section is immune from disciplinary or adverse administrative actions from the
Board of Pharmacy and is immune from civil liability in the absence of gross
negligence or wilful misconduct. A pharmacist shall be deemed to have acted
with reasonable care when acting in accordance with rules or procedures adopted
by the Board of Pharmacy pursuant to this section.
    (E) Nothing
in this section requires a pharmacist to:
       (1)
dispense ivermectin, when in the pharmacist's professional judgment, dispensing
may jeopardize the health or safety of the patient; or
       (2)
stock ivermectin.
    (F)
Nothing in this section shall be construed to require a health insurance issuer
to provide coverage for the cost of ivermectin dispensed pursuant to the
provisions of this section or to prevent a pharmacist from charging an
administrative or dispensing fee for the services provided pursuant to this
section.
SECTION 2.  This act takes effect upon approval
by the Governor.
----XX----
This web page was last updated on May 14, 2026 at 10:47 AM